Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Array BioPharma Company Profile (NASDAQ:ARRY)

Consensus Ratings for Array BioPharma (NASDAQ:ARRY) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $6.35 (67.55% upside)

Analysts' Ratings History for Array BioPharma (NASDAQ:ARRY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/19/2014ZacksDowngradeOutperform -> Neutral$5.40ViewTweet This Rating  Share This Rating on StockTwits
1/21/2014ZacksUpgradeNeutral -> Outperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2013ZacksDowngradeOutperform -> Neutral$6.40ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013ZacksUpgradeNeutral -> Outperform$5.80ViewTweet This Rating  Share This Rating on StockTwits
11/1/2013BMO Capital MarketsBoost Price TargetMarket Perform$3.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Jefferies GroupBoost Price TargetBuy$7.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Stifel NicolausBoost Price TargetBuy$7.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Leerink SwannReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Jefferies GroupReiterated RatingBuy$6.50 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Jefferies GroupBoost Price TargetBuy$6.00 -> $6.50ViewTweet This Rating  Share This Rating on StockTwits
3/25/2013Piper JaffrayUpgradeNeutral -> Overweight$4.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2012Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/26/2012Brean CapitalInitiated CoverageBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2012Leerink SwannUpgradeMarket Perform -> Outperform$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2012Jefferies GroupReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/5/2012Jefferies GroupReiterated RatingBuy (N/A)ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2012 forward)